Paster and Morgan said the most commonly proscribed drug is Gabapentin, originally developed for the treatment of epilepsy. “It helps but there are definite ...
all 12 news articles
We expect to have several near term announcements including the release of Phase II active controlled results of our NP-1 cream vs. gabapentin in post ...
XP13512 is a patented, new chemical entity that is designed to improve upon the clinical utility of gabapentin by taking advantage of high-capacity ...
We expect to have several near term announcements including the release of Phase II active controlled results of our NP-1 cream vs. gabapentin in post ...
XP13512 is a patented, new chemical entity that is designed to improve upon the clinical utility of gabapentin by taking advantage of high-capacity ...
Product candidate Gabapentin GR(TM) is currently in clinical development for the treatment of neuropathic pain and for menopausal hot flashes. ...
12, 2008 (Thomson Financial delivered by Newstex) -- Depomed Inc. (NASDAQ:DEPO) Tuesday said data from a Phase II trial evaluating Gabapentin GR for the ...
The 124 patient study showed that Gabapentin GR, an extended release formulation of gabapentin developed using Depomed’s AcuForm™ drug delivery technology, ...
Doctors say initial treatments usually involve anti-convulsants such as carbamazepine and gabapentin. The medicines start at a low dose and gradually ...